Phigenix, Inc. Announces Issuance of U.S. Patent Covering Precision Medicine Diagnostic and Novel Therapeutic for Treating Drug-Resistant Breast Cancer
Issuance of U.S. Patent No. 11,033,628 Further Bolsters Phigenix’s Intellectual Patent Portfolio ATLANTA, June 15,…
New Aerospike Workshops Deliver Hands-on Build of Real-Time Feature Stores for Predictive, Generative, and Agentic AI Apps